| Serial Number | 98922836 |
| Word Mark | MAVATAR |
| Filing Date | Thursday, December 26, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 23, 2025 |
| Goods and Services | Provision of access to databases; Provision of access to databases containing biomedical data. |
| Goods and Services | Pharmaceutical preparations, namely, medical diagnostic reagents for identifying treatment response in oncology and inflammatory diseases; diagnostic biomarker reagents for medical purposes. |
| Goods and Services | Compiling of biomedical data into computer databases for business purposes; providing online business organization workflow information to pharmaceutical companies to enable streamlining of drug discovery and development. |
| Goods and Services | Research and development services in the field of medical preparations; Medical and scientific research and development services in the fields of precision medicine and pharmaceutical drug development; biomedical research services; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for integrating model data with biomedical data of patients to create a digital twin of a patient; Software as a service (SAAS) services featuring software for integrating model data with biomedical data of a patient to create a digital twin of a patient; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for integrating model data with biomedical data to create a digital twin of a patient; Software as a service (SAAS) services featuring software for integrating model data with biomedical data to create a digital twin of a patient; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for research and analysis of medical and biomedical data; Software as a service (SAAS) services featuring software for research and analysis of medical and biomedical data; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular and biomarker data; Software as a service (SAAS) services featuring software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging and modifying genetic, genomic, molecular and biomarker data; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; Software as a service (SAAS) services featuring software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information for use by pharmaceutical companies and healthcare providers; Software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information for use by pharmaceutical companies and healthcare providers; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for developing drugs by simulating patient responses to medications; Software as a service (SAAS) services featuring software for developing drugs by simulating patient responses to medications; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for predicting patient treatment response; Software as a service (SAAS) services featuring software for predicting patient treatment response; providing medical and scientific research information; information services relating to pharmaceutical drug development; information services provided via the internet, namely providing information to pharmaceutical companies to streamline drug discovery and development; providing online pharmaceutical drug research information via the internet to pharmaceutical companies to enable streamlining of drug discovery and development; providing scientific analysis related to genetic, genomic, molecular, and biomarker data; software as a service (SAAS) services featuring software that enables users to access, track, monitor and generate informational reports based upon results of genetic, genomic, molecular, and biomarker data. |
| Goods and Services | Downloadable software for medical diagnostics; downloadable databases in the fields of medical information, medical research, medical diagnostics and medical treatments; Downloadable artificial intelligence software that integrates model data with biomedical data of patients to create a digital twin of a patient; Downloadable artificial intelligence software that integrates model data with biomedical data to create a digital twin of a patient; Downloadable software for research and analysis of medical and biomedical data; Downloadable software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular, and biomarker data; Downloadable software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; Downloadable software for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information for use by pharmaceutical companies and healthcare providers; Downloadable software for developing drugs by simulating patient responses to medications; Downloadable software for predicting patient treatment response; downloadable databases containing biomedical data. |
| Goods and Services | Healthcare information services; healthcare consultancy services; healthcare services; Medical information services provided via the Internet, namely providing personalized treatment suggestions to medical professionals tailored after their patients' health profile; Medical information services provided via the Internet, namely providing medical information to pharmaceutical companies to streamline drug discovery and development; Provision of medical information from online databases. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 038 - Services allowing people to communicate with another by a sensory means. |
| US Class Codes | 100, 101, 104 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 038 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AB MAvatar |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Helsingborg 25481 SE |
| Party Name | AB MAvatar |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Helsingborg 25481 SE |
| Event Date | Event Description |
| Thursday, December 26, 2024 | NEW APPLICATION ENTERED |
| Monday, April 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 10, 2025 | ASSIGNED TO EXAMINER |
| Monday, June 16, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, June 16, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, June 16, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 25, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, August 25, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, August 25, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 25, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 25, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 25, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 1, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, December 1, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, December 1, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, December 1, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, December 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 17, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 23, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 23, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |